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Abstract
Woolly monkey hepatitis B virus (WMHBV) is a new member of Hepadnaviridae that was isolated from a New World monkey and is
phylogenetically distinct from the HBV family. In this study, we explored the functional significance of sequence divergence in the HBV
and WMHBV genomes. Independently expressed TP and RT domains of the WMHBV reverse transcriptase (Pol) formed a complex
functional for in vitro nucleotide priming, consistent with previous results from priming reactions conducted with HBV. Transcomple-
mentation assays between HBV and WMHBV TP and RT components for in vitro priming demonstrated functional compatibility, although
priming with the combination of WMHBV RT and HBV TP was reduced. Examination of cross-species protein-protein interactions revealed
that WMHBV core coprecipitated with HBV TP and RT, as well as with WMHBV TP and RT. Analysis in Huh7 cells revealed that
WMHBV core and Pol complemented core-negative and Pol-negative HBV mutant genomes for replication. These results highlight the
conservation of function despite significant sequence divergence in these viruses.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
A current challenge encountered in HBV research is that
infections are remarkably species specific, with permissive
hosts for viral replication extending only to humans and
apes. This narrow host range and the absence of a cell
culture system to study virus propagation restrict efforts to
understand the very basis of viral infectivity and pathogen-
esis. Progress in this area has been greatly facilitated by the
development of several nonprimate animal models of HBV
infection. Hepadnavirus animal models include duck HBV
(Mason et al., 1980), heron hepatitis virus (Sprengel et al.,
1988), woodchuck hepatitis virus (Summers et al., 1978),
ground squirrel hepatitis virus (Marion et al., 1980), and
arctic ground squirrel hepatitis virus (Testut et al., 1996).
These small animal models continue to contribute to current
knowledge of the molecular biology of HBV infection;
however, the viral genomes are considerably divergent from
human HBV. In addition, the metabolism of each of these
host animals is very different from that of a human. The
chimpanzee is the only animal model to study infections
with human HBV, but chimpanzees are highly intelligent
and very expensive. Therefore, the development of small
primate models of hepadnavirus infection that are closely
related to human HBV would aid in characterizing the
genetic basis for biological properties that contribute to
differences in host range and pathogenesis.
A primate hepadnavirus was recently isolated from a
New World monkey, the woolly monkey, and designated
woolly monkey hepatitis B virus (WMHBV) (Lanford et al.,
1998). The woolly monkey from which the virus was iso-
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lated experienced fulminant hepatitis that resulted in death
of the animal (Lanford et al., 1998). Approximately 80% of
the offspring of infected woolly monkey females were pos-
itive for WMHBV, suggesting a pattern of vertical trans-
mission similar to HBV (Lanford et al., 1998). The closest
nonendangered relative of the woolly monkey, the black-
handed spider monkey, is susceptible to infection with WM-
HBV (Lanford et al., 1998). This host-virus system repre-
sents an improved small animal model that reduces the
divergence inherent in the duck and woodchuck counter-
parts of hepadnavirus infection.
The WMHBV genome has the same genetic organization
as human HBV (Fig. 1) (Lanford et al., 1998). WMHBV
core is the most conserved, exhibiting approximately 15%
divergence at the amino acid level and 24% divergence at
the nucleotide level compared to human HBV core. WM-
HBV X is the least conserved, exhibiting approximately
35% divergence between woolly monkey and human HBV
at the amino acid level. The overlapping preS1 and spacer
domains of the polymerase open-reading frames (ORF) con-
tain a high level of divergence contributing to 32 and 30%
difference at the amino acid level, respectively. An align-
ment of the amino acid sequence between HBV Pol and
WMHBV Pol is depicted in Fig. 2B.
The HBV polymerase open-reading frame is 832 amino
acids and is composed of four domains (Fig. 2A). The TP
domain, or terminal protein, is the portion of Pol that is
covalently bound to minus-strand DNA, and is followed by
the spacer domain. The RT domain contains the YMDD
consensus sequence at amino acid 538 that is the catalytic
site for reverse transcriptases. The RNaseH domain is con-
tained within amino acids 680–832 and degrades the pre-
genomic RNA inside the capsid after reverse transcription.
Following translation of polymerase from the pregenomic
RNA molecule (pgRNA), the polymerase binds preferen-
tially to the 5 copy of an epsilon stem loop structure on its
own pgRNA molecule, that also serves as the encapsidation
signal (Bartenschlager et al., 1990). After binding the en-
capsidation signal, epsilon, Pol functions as a protein primer
for the initiation of reverse transcription in a process called
nucleotide priming or protein-primed reverse transcription
(Tavis and Ganem, 1993; Wang and Seeger, 1992). Both the
TP and the RT domains of Pol are required for protein
priming (Lanford et al., 1997; Wang and Seeger, 1992;
Zoulim and Seeger, 1994).
Studies with baculoviruses expressing Pol in insect cells
demonstrated that purified Pol is active in nucleotide prim-
ing and reverse-transcription reactions (Lanford et al.,
1995). Independently expressed TP and RT polypeptides
are able to interact and form a complex functional in nu-
cleotide priming and reverse transcription (Lanford et al.,
1997). Pol proteins expressed in the baculovirus system
were utilized to map the minimal functional domains for
priming, as well as the protein-protein interactive sites be-
tween the TP and the RT domains of Pol (Lanford et al.,
1999). The requirements for protein priming by full-length
Pol are complex. The Pol-epsilon interaction induces a
conformational change in Pol to an active state (Tavis and
Ganem, 1996). In addition to binding epsilon, interactions
with cellular chaperone proteins (Hu et al., 1997) and the
viral core protein may be involved in changes in the con-
formational state of Pol associated with priming, encapsi-
dation, and multiple steps in genomic replication. Charac-
terization of a virus closely related to human HBV may lead
to an improved understanding of the functional interactions
between the TP and the RT domains of Pol and core, and the
contribution of these interactions to the processes of encap-
sidation and genomic replication.
In this study, we examined the capacity of specific WM-
HBV proteins to interact with and complement HBV pro-
teins and participate in HBV replication. We show that
WMHBV TP and RT formed a complex active in nucleotide
priming when concomitantly expressed in insect cells.
Cross-species transcomplementation for in vitro priming
reactions between HBV and WMHBV TP and RT compo-
nents revealed functional compatibility. We previously pro-
vided evidence for a protein-protein interaction between
HBV core and Pol (Lott et al., 2000). Here we report that
WMHBV core coprecipitates with WMHBV TP and RT,
and with HBV TP and RT as well. Utilizing the endogenous
polymerase assay, we analyzed transcomplementation of
core and Pol functions, first in insect cells and then in
human liver cells. The results revealed that WMHBV core
complements a core-defective HBV genome, and that WM-
HBV Pol complements a Pol-defective HBV genome for
replication. Cross-species transcomplementation was re-
duced as compared to transcomplementation with HBV
proteins.
Fig. 1. Genetic organization of the HBV and WMHBV genomes. The
genome within the nucleocapsid, depicted by the inner circle, is partially
double-stranded, noncovalently closed circular DNA with Pol covalently
bound to the 5 end of minus-strand DNA. The two boxes, DR1 and DR2,
represent sequences involved in HBV replication. The outer bars illustrate
the HBV and WMHBV ORFs.
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Fig. 2. (A) Domain structure of HBV Pol. The polymerase open-reading frame is 832 amino acids and is composed of four domains. The TP domain is the
portion of Pol that is covalently bound to minus-strand DNA by the tyrosine at residue 63. The TP domain is followed by the spacer domain. The RT domain
contains the YMDD consensus sequence at amino acid 538 that is the catalytic site for reverse transcriptases. The RNaseH domain is contained within amino
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Results
Transcomplementation for nucleotide priming between
WMHBV and HBV TP and RT
Previous studies utilizing baculoviruses expressing HBV
Pol in insect cells demonstrated that purified Pol is active in
protein-primed reverse-transcription reactions (Lanford et
al., 1995). To ensure that WMHBV Pol possessed similar
priming activity as HBV Pol when expressed in insect cells,
HBV, and WMHBV full-length constructs were compared
for in vitro priming activity. In addition to analyzing full-
length Pol proteins in nucleotide priming reactions, we also
analyzed the ability of the WMHBV TP and RT domains to
complement the HBV TP and RT domains in protein prim-
ing and reverse transcription. Previous studies demonstrated
that full-length Pol proteins with mutations in the TP or RT
domains are not capable of complementation for nucleotide
priming or reverse-transcription reactions (Lanford et al.,
1997). However, independent expression of the TP and RT
domains of Pol within the same cells results in the formation
of a stable RNP complex that is active in nucleotide priming
(Lanford et al., 1997). Therefore, to analyze cross-species
complementation of polymerase functions, we examined the
ability of WMHBV TP and RT polypeptides to interact and
complement each other as well as HBV TP and RT in
nucleotide priming reactions. Each Pol construct analyzed
for in vitro priming activity contained an amino-terminal
FLAG epitope for immunoprecipitation with anti-FLAG
affinity beads (M2). Insect cells were infected with full-
length Pol constructs, or coinfected with TP and RT ex-
pressing baculoviruses. Pol polypeptides were immunopre-
cipitated with anti-FLAG antibodies and priming reactions
were conducted with the Pol polypeptides bound to the
beads. The positive controls were priming reactions with
full-length HBV and WMHBV Pol proteins (Fig. 3A).
When the primed product was examined by SDS-PAGE
analysis, the WM Pol band was labeled by the covalent
attachment of radiolabeled nucleotides and migrated at a
molecular weight of approximately 84,000. A labeled smear
extended up the gel as higher molecular weight material
from the WM Pol band, indicative of elongation of the
primed product by reverse transcription. For comparison, a
priming reaction with full-length HBV Pol is shown (Fig.
3A). No significant difference in priming ability was ob-
served between the full-length Pol proteins. Independently
expressed WMHBV TP and RT formed a complex func-
tional for in vitro nucleotide priming, consistent with prim-
ing by human HBV TP and RT. The HBV TP polypeptide
that extends from amino acids 1–199 had a molecular
weight of 26,500, and the WMHBV TP polypeptide (WM
TP) that extends from amino acids 1–225 migrated slightly
above the HBV TP band. The labeled TP bands form a
smear extending up the gel due to elongation of the primed
product. Transcomplementation assays between HBV TP
plus WMHBV RT and WMHBV TP plus HBV RT for in
vitro priming demonstrated functional cross-species com-
patibility. However, priming with WMHBV TP and human
HBV RT was reduced, and elongation of the primed product
with this combination of WMHBV and HBV Pol polypep-
tides was not observed. A comparison of the immunopre-
cipitates by a Coomassie blue staining of the gel confirmed
that the low priming activity was not due to the low expres-
sion of WMHBV TP or HBV RT (Fig. 3B).
Protein-binding interactions between WMHBV and HBV
core and Pol
The mechanism by which the HBV capsid assembles
into a replication-competent particle remains to be deter-
mined. Core harbors DNA and RNA-binding abilities in
vitro; however, the method by which core specifically rec-
ognizes the Pol-epsilon ribonucleoprotein complex for en-
capsidation among many cellular RNA molecules is not
completely understood. Recent evidence for a protein-pro-
tein interaction between HBV core and Pol may begin to
explain the unique specificity of HBV encapsidation (Lott et
al., 2000). Mutagenesis studies utilizing the baculovirus
expression system revealed at least three core-binding sites
on HBV Pol, within the TP, RT, and RNaseH domains.
These interactions were dependent on expressing core and
Pol within the same cells. Furthermore, capsid formation is
required, although not sufficient for these interactions (Lott
et al., 2000). In this analysis, we evaluated the conservation
of core-Pol interactions in WMHBV by analyzing the abil-
ity of WMHBV core to interact and coprecipitate with
WMHBV TP and RT. Insect cells were coinfected with
baculoviruses expressing WMHBV core and WMHBV TP
or RT. A fraction of the total cell lysate (1/20) from each
infection was immunoblotted with anti-core antibodies and
confirmed the expression of core at equivalent levels (Fig.
4A). Immunoprecipitation of the remaining cell lysate was
performed with anti-FLAG antibodies for the Pol polypep-
tides. The negative control was a single infection with
WMHBV core immunoprecipitated with anti-FLAG anti-
bodies. Western blot analysis with anti-core antibodies re-
vealed a conservation of core-Pol interactions. WMHBV
core coprecipitated with both WMHBV TP and WMHBV
RT (Fig. 4B). We next evaluated cross-species core-Pol
interactions. Insect cells were coinfected with baculoviruses
expressing WMHBV core and HBV TP or RT. Although
previous core mutagenesis studies demonstrated that the TP
acids 680–832. (B) Alignment of HBV and WMHBV Pol amino acid sequences. The WMHBV Pol 1 sequence was obtained from the original WMHBV
sequence that was determined from the serum of a Woolly monkey exhibiting fulminant hepatitis (GenBank Accession No. AF046996). The WMHBV Pol
2 sequence was obtained by direct coning of cccDNA from the liver of an infected animal and represents the sequence of an infectious clone (Lanford et
al., in preparation).
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and RT domains of HBV Pol have different requirements
for interaction with core (Lott et al., 2000), the results of this
cross-species analysis revealed that WMHBV core coim-
munoprecipitated with both HBV TP and RT (Fig. 4).
Transcomplementation of WMHBV and HBV core and
Pol for endogenous polymerase activity in insect cells
The natural environment of HBV genomic replication is
the interior of the capsid particle. Previous studies utilized
baculoviruses expressing HBV Pol and core to reconstitute
HBV Pol activity within capsid particles produced in insect
cells (Seifer et al., 1998). To analyze Pol activity inside the
capsid, a method was utilized termed the endogenous poly-
merase assay, in which radiolabeled nucleotides are added
to DNA by Pol in association with the capsid particle. In this
analysis, we utilized a similar approach to compare HBV
and WMHBV Pol activity in capsid particles assembled in
insect cells. Nucleocapsids were collected by immunopre-
cipitation with anti-core antibodies. Endogenous polymer-
ase reactions were performed with the capsids still bound to
the affinity beads and the radiolabeled DNA products were
analyzed by agarose gel electrophoresis. The results dem-
Fig. 3. Transcomplementation for nucleotide priming between WMHBV
and HBV TP and RT. (A) Insect cells were infected with baculoviruses
expressing HBV Pol or WM Pol or compare priming activities of the
full-length Pol proteins. Insect cells were coinfected with baculoviruses
expressing WM TP plus HBV RT, WM RT plus HBV TP, HBV TP plus
HBV RT, or WM TP plus WM RT. Immunoprecipitation was performed
with anti-FLAG antibodies followed by priming reactions and SDS-PAGE
analysis to evaluate priming activity. Priming between WM TP and HBV
RT was reduced. (B) Coomassie blue staining of the Pol proteins. The
upper asterisk represents the position of WM RT that comigrates with an
insect cell protein. HBV RT migrates slightly higher on the gel than WM
RT due the construct differences. The lower asterisk represents the position
of HBV TP that comigrates with the IgG light chain from the M2 beads.
The WM TP polypeptide migrated slightly higher on the gel than HBV TP
due to the construct differences.
Fig. 4. Protein-binding interactions between WMHBV and HBV core and
Pol. Insect cells were coinfected with baculoviruses expressing WM core
and WM TP, WM RT, HBV TP, or HBV RT. (A) A fraction (1/20) of the
cell lysate was immunoblotted with anti-core antibodies to confirm that the
core protein was expressed at similar levels. (B) Immunoprecipitation was
performed with anti-FLAG antibodies to the Pol polypeptides followed by
Western blot analysis with anti-core antibodies. A negative control was
single infection with baculoviruses expressing WM core. WM core copre-
cipitates with TP and RT polypeptides derived from both WMHBV and
HBV.
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onstrated that coinfection of insect cells with WMHBV core
and Pol resulted in similar endogenous polymerase activity
as observed using HBV core and Pol (Fig. 5). Although this
system produces particles with endogenous polymerase ac-
tivity, the DNA product does not represent partially double-
stranded, noncovalently closed DNA as is seen in endoge-
nous polymerase reactions from HBV capsids produced
during authentic replication. Based on mobility on agarose
gels, the products represent single-stranded DNA of less
than 1000 nucleotides in length. Cross-species transcomple-
mentation between WMHBV core and HBV Pol or WM-
HBV Pol with HBV core also supported packaging and
DNA synthesis as revealed by the endogenous polymerase
assay (Fig. 5). As a negative control, capsid particles from
a single infection with core expressing baculoviruses were
examined and no activity was observed. A fraction of the
total cell lysate (1/20) from each infection was immuno-
blotted with anti-core antibodies and confirmed the expres-
sion of core at equivalent levels (data not shown).
Cross-species transcomplementation of WMHBV and HBV
core and Pol for replication in mammalian cells
To evaluate HBV replication in the context of the entire
genome, transcomplementation reactions were examined
following expression in the human liver cell line, Huh7. For
these studies, a plasmid construct expressing WMHBV Pol
from the CMV promoter was used to complement a con-
struct containing 1.3 copies of an HBV genome defective
for Pol synthesis (HBVPol). For comparison, HBV repli-
cation was also examined when HBV Pol was provided to
HBVPol in trans. Cotransfections were conducted in trip-
licate and the cell lysates were prepared 72 h posttransfec-
tion. Immunoprecipitations were performed with anti-core
antibodies followed by endogenous polymerase reactions
and analysis by agarose gel electrophoresis. Unlike the
endogenous polymerase activity observed in insect cells,
this reaction fills in the single-stranded gap in partially
double-stranded DNA located within the nucleocapsid to
obtain relaxed circular DNA, or in the absence of appropri-
ate strand transfer the reaction completes second-strand
DNA synthesis to yield linear dsDNA. Plasmids expressing
1.3 copies of the wild-type WMHBV and HBV genomes
(GGL) were active in the endogenous polymerase reactions
(Fig. 6A). When provided in trans, HBV Pol complemented
a Pol-defective HBV genome for replication in this system
(Fig. 6A). The results of cross-species transcomplementa-
tion revealed that WMHBV Pol complemented a Pol-defec-
tive HBV genome, although at a reduced level compared to
human HBV Pol (Fig. 6A). This suggests that WMHBV Pol
is recognized for packaging by human HBV core and that
WMHBV Pol reverse-transcribes an HBV genome. An en-
dogenous polymerase reaction with HBVPol was negative
in this assay.
To evaluate transcomplementation with the WMHBV
core protein, a construct expressing HBV or WMHBV core
was used to complement a construct expressing a core-
defective HBV genome (HBVcore). Immunoprecipitation
was performed with anti-core antibodies to collect nucleo-
capsids, followed by endogenous polymerase reactions and
agarose gel electrophoresis. The endogenous polymerase
assay with the HBVcore-defective genome was negative.
A fraction from each of the other total cell lysates (1/20)
was immunoblotted with anti-core antibodies and confirmed
the expression of core at similar levels (data not shown).
Transcomplementation between WMHBV core and a core-
negative HBV mutant genome demonstrated functional
compatibility at a reduced level as compared to
transcomplementation with human HBV core (Fig. 6B). The
fact that WMHBV core complements a human HBV ge-
nome in the endogenous polymerase assay suggests that
WMHBV core supports packaging of HBV Pol and pre-
genomic RNA molecules, as well as sustains HBV reverse
transcription and DNA replication.
Fig. 5. Transcomplementation of WMHBV and HBV core and Pol func-
tions for endogenous polymerase activity in insect cells. Insect cells were
coinfected with baculoviruses expressing WM core plus WM Pol, WM
core plus HBV Pol, HBV core plus HBV Pol, or HBV core plus WM Pol.
Immunoprecipitation was performed with anti-core antibodies followed by
endogenous polymerase reactions, DNA purification, and agarose gel elec-
trophoresis. WM core plus WM Pol and HBV core plus HBV Pol were
active in the endogenous polymerase assay. Cross-species transcomple-
mentation between WM core plus HBV Pol and HBV core plus WM Pol
was also positive in the endogenous polymerase assay. A negative control
was single infection with baculoviruses expressing HBV core.
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Discussion
The objective of this study was to decipher the biological
significance of sequence divergence between the human and
woolly monkey hepatitis B viruses through transcomple-
mentation assays using both the baculovirus insect cell
system and transfections in mammalian cells. Conserved
hepadnaviral protein function was previously analyzed by
evaluating cross-species transcomplementation for encapsi-
dation between the HBV and woodchuck hepatitis B virus
(WHV) genomes to better understand the macromolecular
interactions responsible for packaging of the Pol-epsilon-
RNP complex (Ziermann and Ganem, 1996). The WHV
genome shares approximately 65% nucleotide sequence ho-
mology with HBV. WHV pgRNA is recognized for pack-
aging by human HBV Pol, and HBV epsilon is sufficient for
interaction with WHV Pol (Ziermann and Ganem, 1996).
However, heterologous packaging was slightly lower, and
cross-species complementation for reverse transcription and
DNA synthesis were not examined (Ziermann and Ganem,
1996).
In our analysis, we examined the significance of se-
quence divergence between HBV and WMHBV by cross-
species transcomplementation for core-Pol interactions, Pol
encapsidation, and genome replication. WMHBV core co-
precipitated with WMHBV TP and RT, as well as HBV TP
and RT. Similar to previous reports with HBV TP and RT
(Lanford et al., 1995), individually expressed WMHBV TP
and RT formed a complex functional for in vitro nucleotide
priming. Cross-species transcomplementation between the
different TP and RT domains also demonstrated functional
compatibility, although the priming between WMHBV TP
and HBV RT was reduced when compared to priming
between WMHBV RT and HBV TP.
Previous studies utilized deletion mutants of the TP and
RT domains of HBV Pol to map the amino acid require-
ments for nucleotide priming activity. Deletions from the
carboxy-terminus of TP beyond amino acid 199 dramati-
cally reduced priming, while deletions to amino acid 175
essentially blocked priming activity. The deletion of 20
amino acids from the amino terminus of the TP domain
resulted in minimal priming, and further deletions abolished
priming altogether (Lanford et al., 1999). This suggests that
a large portion of the TP domain is involved in bringing the
hydroxyl group of the tyrosine at amino acid 63 of the TP
domain into a precise fit with the catalytic pocket of the RT
domain for priming. Yet, our results demonstrated that
WMHBV TP was capable of interacting with HBV RT to
support nucleotide priming despite the divergence in the
amino acid sequences.
In the nucleotide priming and endogenous polymerase
assays, the template for the short, radiolabeled DNA prod-
uct for priming by Pol expressed in insect cells is unknown.
In previous studies utilizing HBV proteins expressed in
insect cells, HBV minus-strand DNA covalently linked to
Pol and plus-strand DNA species were isolated from capsid
particles (Seifer et al., 1998). The 5 ends of minus-strand
DNA mapped to the authentic elongation origin DR1 (Seifer
et al., 1998). Although the presence of an epsilon stem loop
structure is not required in core-Pol interactions, Pol encap-
sidation, or protein priming with full-length Pol, an RNA
template is required (Lanford et al., 1995; Lott et al., 2000;
Seifer et al., 1998). In this analysis, Pol may be priming
from the epsilon engineered on the 3 end of the Pol mRNA,
Fig. 6. Cross-species transcomplementation of WMHBV and HBV core
and Pol functions for replication in mammalian cells. (A) Huh7 cells were
cotransfected with a greater-than-genome length HBV construct defective
for Pol activity (HBV Pol) and a construct expressing WM Pol or HBV
Pol, or (B) with a greater-than-genome length HBV construct defective for
core activity (HBV core) and a construct expressing WM core or HBV
core, in triplicate. Immunoprecipitation was performed with anti-core an-
tibodies followed by endogenous polymerase reactions, DNA purification,
and agarose gel electrophoresis. WM Pol complemented HBV Pol and
WM core complemented HBV core, at reduced levels as compared to
transcomplementation with HBV proteins. HBVGGL and WMGGL rep-
resent endogenous polymerase reactions from single transfections with
constructs expressing 1.3 copies of the HBV or WMHBV genomes. Neg-
ative controls were single transfection with HBV Pol or HBV core.
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a cryptic site on Pol mRNA, or possibly from an endoge-
nous insect cell RNA molecule that mimics epsilon.
By analyzing HBV replication in Huh7 cells, we dem-
onstrated that WMHBV Pol is recognized for packaging by
HBV core and that WMHBV Pol can substitute for HBV
Pol in performing the complex series of interactions re-
quired to complete HBV genome replication. Cross-species
transcomplementation exhibited reduced activity as ob-
served by the endogenous polymerase assay as compared to
HBVPol HBV Pol complementation. Transcomplemen-
tation utilizing the reciprocal counterparts between species
such as WMHBVPol  HBV Pol was not examined.
However, the observation that nucleotide priming activity
between the WMHBV TP and HBV RT polypeptides was
reduced when compared to priming between WMHBV RT
and HBV TP suggests that cross-species transcomplemen-
tation may lack reciprocity.
The partial functional compatibility of HBV and WM-
HBV is not entirely surprising due to the fact that the HBV
and WMHBV genomes exhibit a significant level of se-
quence divergence. The WMHBV polymerase is approxi-
mately 30% divergent at the amino acid level from HBV
Pol. WMHBV core is the most conserved domain, exhibit-
ing approximately 15% divergence at the amino acid level
and 24% divergence at the nucleotide level compared to
human HBV core. Nonetheless, the WMHBV core recog-
nizes HBV Pol for packaging and supports replication of a
human HBV genome. The function of WMHBV X protein
was also recently examined and found to have conserved
transactivating and proapoptotic activity (Schuster et al.,
2002). At the amino acid level, the WMHBV X protein is
approximately 34% divergent as compared to the human
HBV X protein. The results of these analyses emphasize the
functional similarities between the woolly monkey and the
human hepatitis B viruses, and specifically demonstrate a
functional conservation of the core-Pol complex formation,
and of TP-RT interactions regardless of the considerable
sequence divergence of these viruses.
Materials and methods
Cells
The SF9 cell line was cultivated as described previously
(Lanford and Notvall, 1990). Briefly, Sf9 cells were main-
tained as spinner cultures in TMN-FH medium consisting of
Grace’s antherea medium (JRH Biosciences) supplemented
with 3.3 g/L yeastolate, 3.3 g/L lactalbumin hydrolysate,
5% fetal bovine serum (FBS) and 0.1% Pluronic F68
(Gibco/BRL). After infections, the medium was changed to
Grace’s medium supplemented with 2% fetal bovine serum.
The human hepatoma cell line Huh7 (Nakabayashi et al.,
1982) was maintained in Dulbecco’s modified Eagle
medium-F12 medium (1:1) plus 10% fetal bovine serum,
2 mM glutamine, and 50 g of gentamicin per milliliter.
Plasmid constructs
HBV sequences of the ayw 2 subtype are numbered as
specified by Galibert and co-workers (Galibert et al., 1979).
The HBV Pol construct was previously described as FPL-
Pol and is comprised of full-length HBV Pol that contains a
10 amino acid FLAG epitope fused to the amino terminus of
Pol (Lanford et al., 1995). The construct was extended
beyond the Pol open-reading frame at the 3 terminus to
include DR1 and epsilon stem loop sequences. All baculo-
viruses expressing Pol were generated as specified previ-
ously (Lanford et al., 1997). The HBV TP construct ex-
pressing the amino terminal 199 amino acids of Pol with a
FLAG epitope was previously designated FTP199. The
HBV RT construct was previously described as FTPL, and
is identical to FPL-Pol, except for a deletion in the TP
domain of Pol from amino acids 7 to 176. The baculovirus
construct expressing HBV core was generated as described
previously (Beames and Lanford, 1993).
The HBVPol construct was previously designated
GGLPol (greater-than-genome length HBV deficient for
Pol synthesis). This construct was a gift of Dr. Chiaho Shih
at The University of Texas Medical Branch, Galveston,
Texas. The construct contains a tandem dimer of the HBV
genome in the MC-3 vector (Roychoudhury and Shih, 1990)
with a point mutation changing the Pol AUG to ACG at
nucleotide 2310. This mutation caused a conversion of
methionine to threonine, while keeping the core protein
unaltered. Characterization of this mutant demonstrated that
no polymerase activity or replicative intermediates could be
detected when GGLPol was transfected into HepG2 cells
(Roychoudhury and Shih, 1990).
A terminally redundant clone containing 1.3 copies of
the HBV genome (HBVGGL) was constructed as previ-
ously described (Beames and Lanford, 1993). Briefly, this
clone begins at nucleotide 1066 and spans the HBV genome
through nucleotide 3182/1 to the BglII site at position 1987,
so that each HBV gene is present once in entirety. Tran-
scription is initiated from the authentic HBV promoters. For
transcomplementation analysis in mammalian cells, this
clone was used to generate the HBVcore construct that is
deficient for core synthesis, as previously described
(Beames and Lanford, 1993). Briefly, a mismatch was cre-
ated that altered the core AUG to AUA, converting a me-
thionine to isoluecine.
For expression in mammalian cells, the HBV core gene
(nt 1903–2454) was inserted into the multiple cloning site of
the pcDNA4/TO vector (Invitrogen). Transcription in this
vector (HBV core) is initiated from the human cytomega-
lovirus (CMV) immediate early promoter that permits high-
level expression in Huh7 cells. The HBV Pol construct used
for transfections was generated from the baculovirus FP-Pol
construct (Lanford et al., 1995) containing a FLAG se-
quence, but lacking the epsilon stem-loop and DR1 se-
quences. FP-Pol was inserted into the multiple cloning site
of pcDNA4/TO.
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All WMHBV constructs were generated from an infectious
clone of WMHBV (Lanford, in preparation) that contains 1.3
copies of the WMHBV genome (WMHBV GGL). The bacu-
lovirus expression vector WM Pol represents a full-length
WMHBV Pol construct that contains a 5 FLAG epitope and
3 DR1 and epsilon sequences. The WMHBV TP construct
(WM TP) contains the amino-terminal 225 amino acids of
WM Pol with a FLAG epitope. The WMHBV RT construct
(WM RT) was generated from the WM Pol construct by
deleting the amino-terminal 225 amino acids and consists of a
FLAG sequence, amino acids 225–832 of WM Pol, and the 3
DR1 and epsilon stem loop sequences.
The WMHBV core clone used for transfections in Huh7
cells (nt 1903–2449) was inserted into pcDNA4/TO (WM
core). The WMHBV Pol clone used for transfections in
Huh7 cells was generated from the baculovirus WM Pol. A
WMHBV Pol fragment lacking the amino-terminal FLAG
sequence and the 3 DR1 and epsilon stem loop sequences
was inserted into the multiple cloning site of pcDNA4/TO
(WM Pol).
Infection with baculoviruses
At approximately 24 h prior to infection, insect cells
were seeded in flasks (Corning Science Products) at a den-
sity of 4.0  106 cells/25 cm2 flask, 1.0  107 cells/75 cm2
flask, or 2.0  107 cells/150 cm2 flask and incubated over-
night at 27°C. Insect cells were infected or coinfected at
about 90% confluency with baculovirus constructs at a mul-
tiplicity of 5 to 10 plaque-forming units (pfu)/cell by the
following protocol. The culture medium was removed and
undiluted virus stock was added to each flask (1 ml per
single infection in a 75 cm2 flask). The cultures were incu-
bated for 1 h at 27°C and Grace’s medium supplemented
with 2% FBS was added to the infected cells to bring the
total volume in a 75 cm2 flask to 10 ml. Cultures were
incubated at 27°C and harvested at 48 h postinfection.
Transfection protocol
Huh7 cells were seeded at a density of 8.0  106 cells/75
cm2 flask and incubated overnight at 37°C in the presence of
5% CO2 prior to transfection. Huh7 cells were approxi-
mately 80% confluent prior to transfection. The transfection
protocol was as follows. The lipid Transit LT1 (Mirus,
PanVera, Madison, WI) was added to 3 ml serum-free
DMEM-F12 for 15 min at room temperature at a ratio of 4
g of lipid to 2 g DNA. The DNA for transfections was
added to the lipid/medium mix and incubated for 15 min at
room temperature. The culture medium was removed from
the Huh7 cells followed by two washes with serum-free
DMEM-F12 medium, and 3 ml medium was left on the
cells. The lipid/DNA/medium mixture was then added to the
cells for transfection. The transfected cultures were incubated
for 6 h at 37°C. Following transfection, the lipid/DNA mixture
was removed from the cells and 10 ml DMEM-F12 supple-
mented with 10% FBS, 2 mM glutamine, and 50 g of gen-
tamicin per milliliter was added to the cells. The cells were
incubated at 37°C for 72 h prior to harvest.
Immunoprecipitation
For preparation of cell lysates, cultures were washed two
times in phosphate-buffered saline (PBS), and extracted in 1
ml PEB (PBS containing 10% glycerol, 0.5% Nonidet P-40,
and protease inhibitors: 100 M leupeptin, 1 mM Pefabloc,
10 M aprotinin, 10 g of pepstatin per ml, and 1 mM
EDTA). The pellet was extracted for 20 min on ice and
clarified at 13,000g for 15 min at 4°C. For immunoprecipi-
tation of Pol, the clarified cell lysates were immunoprecipi-
tated with anti-FLAG affinity beads for 2 h at 4°C (M2
monoclonal antibody beads; Sigma). To analyze protein-
protein interactions between Pol and core, the beads were
washed three times with WB (WB; 50 mM Tris, 100 mM
NaCl, 1.0% NP-40, 1.0% Na deoxycholate, 0.1% SDS, pH
8.0) to reduce the background of core sticking to the beads.
Nucleotide priming reactions
Following immunoprecipitation with anti-FLAG anti-
bodies as described above, the beads were washed one time
with TNG (100 mM Tris HCl [ph 7.5], 30 mM NaCl, 10%
glycerol), one time with TNG containing 1 M NaCl, and a
final time with TNM (100 mM Tris-HCl [pH 7.5], 30 mM
NaCl, 10 mM MgCl2) as previously described (Lanford et
al., 1999). Nucleotide priming reactions were conducted
with the Pol polypeptides still bound to the M2 affinity
beads. After the third wash, the beads were suspended in
TNM containing 100 M unlabeled deoxyribonucleoside
triphosphates (dATP, dGTP, and dCTP) and 5 Ci of
[-32P]TTP (3000Ci/mmol; NEN). Priming reactions were
performed at 30°C for 30 min and a final wash was per-
formed with PBS to remove excess labeled TTP.
The endogenous polymerase assay
For analysis of the endogenous polymerase activity uti-
lizing capsids produced in insect cells, 1.5 mM phosphono-
formic acid (PFA) was added to the cultures every 24 h
prior to harvesting to block elongation of the primed-Pol
product. No PFA was added to mammalian cells. To collect
capsid particles, lysates were immunoprecipitated at 4°C for
2 h using a rabbit anti-core antiserum bound to protein
A-agarose beads (Repligen, Cambridge, MA). Following
immunoprecipitation with anti-core antibodies, the beads
were washed two times with endogenous polymerase buffer
(EP buffer; 50 mM Tris, 75 mM NH4Cl, 1.0 mM EDTA, 20
mM MgCl2, 0.1 mM -mercaptoethanol, 0.5% Tween [pH
7.4]) and the endogenous polymerase assay (Kaplan et al.,
1973) was performed as previously described (Beames and
Lanford, 1993). The HBV capsids bound to protein A-aga-
rose beads were resuspended in EP buffer containing 100
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M unlabeled deoxyribonucleoside triphosphates (dATP,
dGTP, and dCTP), and 5 Ci of [-32P]TTP (3000 Ci/
mmol; NEN) and were incubated at 37°C for 6 h. The
supernatant was removed and the beads were washed with
EP buffer to remove unincorporated [32P]dTTP. The prod-
ucts of the endogenous polymerase reactions were digested
with proteinase K (1 mg/ml) in TENS buffer (TENS; 10
mM Tris [pH 7.4), 10 mM NaCl, 10 mM EDTA, 1% SDS)
for 2 h at 65°C. DNA was extracted with phenol and then
chloroform with isoamyl alcohol and was ethanol-precipi-
tated. The DNA products were electrophoresed on a 1%
agarose gel in 1X TAE (0.04 M Tris-acetate, 2 mM EDTA)
at 100V for 4 h. The gels were fixed in 7.5% trichloroacetic
acid, dried, and visualized by autoradiography.
SDS-PAGE and immunoblot analysis
Immunoprecipitated complexes were disrupted in elec-
trophoresis sample buffer containing 2% sodium dodecyl
sulfate (SDS) and 2% 2-mercaptoethanol and were heated to
100°C for 10 min. Proteins were separated by SDS-poly-
acrylamide gel electrophoresis (PAGE) as previously de-
scribed (Laemmli, 1970; Lanford and Butel, 1979), and
immunoblot analysis was performed by electrophoretically
transferring proteins to a Flurotrans polyvinylidene difluo-
ride blotting membrane (Pall Biosupport, Glen Cove, NY).
Membranes were processed as previously described (Lan-
ford et al., 1989) using iodinated M2 monoclonal antibody
to detect the FLAG epitope on Pol, or with a rabbit anti-core
antibody followed by 125I-protein A (NEN, Boston, MA).
Protein bands were visualized by autoradiography.
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